Tela Bio rises on marketing clearance for cosmetic surgery implant

TELA Bio

23/03/2023 14:54

** Shares of medical equipment maker Tela Bio Inc  TELA.O 
up 1.2% at $9.99 
    ** The U.S. FDA grants marketing clearance for co's implant
product, OviTex PRS, used in plastic surgeries 
    ** OviTex PRS is resorbable over long-term and is intended
for soft tissue repair or reinforcement in reconstructive
surgery
    ** Shares down 17% in last 12 months

 (Reporting by Aditya Samal)
 ((Aditya.Samal@thomsonreuters.com;))